Author: Gary P. Pisano
Edition: 1
Publisher: Harvard Business School Press
Binding: Hardcover
ISBN: 1591398401
Science Business: The Promise, the Reality, and the Future of Biotech
Why has the biotechnology industry failed to perform up to expectations - despite all its promise? In "Science Business", Gary P. Medical books Science Business. Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotech's problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear prescriptions for companies, investors, and policy makers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business Medical books Synthetic Biology Science Business and Policy. ltp align=quotjustifyquotgt ltspan lang=quotENquotgtampquotSolomon presents a policy framework for self-regulation of the promising new field of synthetic biology . . . The volume begins with background chapters on scientific explanations of the origins of life the chemical basis for life as revealed by molecular biology and recent research on reading the genetic code and sequencing the human genome.ampquotltspangtltpgt ltp align=quotrightquotgt ltspan lang=quotENquotgtampmdashBook News Inc.ltspangtltpgt ltp align=quotjustifyquotgt ltspan lang=quotENquotgtSynthetic biology the modification of artificial genetic code is the future of medicine. Creating organs in the lab developing disease-fighting proteins and creating life-changing pharmaceutical applications are all examples of this new technology. Arguing for self-regulation by the scientific and business communities Lewis D. Solomon recommends a policy framework that would guard against governmental overregulation which could create a barrier to innovation. Although synthetic biotechnology holds considerable social and economic potential absent a nurturing regulatory climate it may prove difficult to translate research discoveries into commercially viable applications.ltspangtltpgt
Download link for Science Business: The Promise, The Reality, And The Future Of Biotech By Gary...
ltp align=quotjustifyquotgt ltspan lang=quotENquotgtampquotSolomon presents a policy framework for self-regulation of the promising new field of synthetic biology . . . The volume begins with background chapters on scientific explanations of the origins of life the chemical basis for life as revealed by molecular biology and recent research on reading the genetic code and sequencing the human genome.ampquotltspangtltpgt ltp align=quotrightquotgt ltspan lang=quotENquotgtampmdashBook News Inc.ltspangtltpgt ltp align=quotjustifyquotgt ltspan lang=quotENquotgtSynthetic biology the modification of
This book is written by Gary P. Pisano Published by Harvard Business School Press In 2006 and is available in Hardback Usually Ships in 3 Days.
Categories: Business Development * General, Organizational Behavior * General. Contributors: Leon Mann - Editor. Format: NOOK Book
Medical Book Science Business
Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotech's problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear prescriptions for companies, investors, and policy makers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business. This character poses three unique business challenges: how to finance highly risky investments under profound uncertainty and long time horizons for R&D, how to learn rapidly enough to keep pace with advances in drug science knowledge, and how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases.The key to fixing the industry? Business models, organisational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorter - term 'monetisation' of intellectual property. Pisano maintains that all industry players - biotech firms, investors, universities, pharmaceutical companies, government regulators - can play a role in righting the industry. The payoff? Valuable improvements in health care, and a shinier future for human well-being.
